Assessment of Safety and Biodistribution of a miniMECP2 AAV9 Vector for Gene-replacement Therapy of Rett Syndrome in Non-human Primates (NHPs)

被引：0
|
作者：
Prasad, S. [1 ]
Flora, G. [1 ]
Newman, M. [1 ]
Gray, S. J. [2 ]
Sinnett, S. [2 ]
Sadhu, C. [1 ]
机构：
[1] Taysha Gene Therapies R&D, Dept Res & Dev, Dallas, TX USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX USA
来源：
HUMAN GENE THERAPY | 2022年 / 33卷 / 23-24期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P238
引用
收藏
页码：A89 / A90
页数：2
相关论文
共 34 条
  • [21] A Human-Ready Regulated AAV9/miniMECP2-miRARE Gene Therapy (TSHA-102) Improves Survival, Weight, and Behavior after Intracerebroventricular (ICV) Dosing in the Neonatal Knockout Rett (RTT) Mouse Model
    Okposo, Kome
    Haque, Emdadul
    Sadhu, Chanchal
    Prasad, Suyash
    Newman, Mary
    Lawlor, Michael W.
    Gray, Steven J.
    Sinnett, Sarah E.
    MOLECULAR THERAPY, 2023, 31 (04) : 644 - 644
  • [22] Absence of toxicity with intravenous dosing of the Exon 2-skipping AAV9.U7-ACCA vector in non-human primates
    Gushchina, L.
    Frair, E.
    Rohan, N.
    Bradley, A.
    Simmons, T.
    Chavan, H.
    Waldrop, M.
    Wein, N.
    Flanigan, K.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S109 - S109
  • [23] Successful repeated hepatic gene delivery in mice and non-human primates achieved by sequential administration of AAV2/5 and AAV1 vector serotypes
    Majowicz, Anna
    Salas, David
    Aseguinolaza, Gloria Gonzalez
    Petry, Harald
    Ferreira, Valerie
    HUMAN GENE THERAPY, 2014, 25 (11) : A53 - A53
  • [24] Assessment of safety and feasibility of a Cas13-based RNA editing therapy for MECP2 duplication syndrome in non-human primates
    Yang, D.
    Wu, X.
    Duan, M.
    Wu, M.
    Wang, S.
    Yao, X.
    Luk, A.
    Shi, L.
    Yang, H.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A272 - A273
  • [25] Safety and Efficacy of an Adeno Associated Virus-Based Vector Carrying the Human Clotting Factor IX Gene (AAV5-hFIX) As Studied in Non-Human Primates
    Nijmeijer, Bart
    Petry, Harald
    Spronck, Lisa
    Van Der Kruijssen, Corina
    Petersen, Jorgen
    Salmon, Florence
    BLOOD, 2014, 124 (21)
  • [26] Preclinical Pharmacology and Toxicology of Intrathecally Infused AAV9-hABCD1 (SBT101), a Gene Therapy Candidate for AMN, in Non-Human Primates
    Vasireddy, Vidyullatha
    Clark, Sean W.
    Cartwright, Mark
    Kozarsky, Karen
    Anderson, David W.
    MOLECULAR THERAPY, 2022, 30 (04) : 82 - 82
  • [27] Advancing Gene Therapy for STXBP1-Related Disorders Through Targeted Vector Engineering: Efficacy and Safety Results in Mice and Non-Human Primates
    Aeran, Rangoli
    Tanenhaus, Annie
    Sears, Sheila
    Moerke, Nathan
    Miller, Adam
    Artur, Camille
    Bouhlal, Yosr
    Bove, Peter
    de Arce, Alex Diaz
    Shimizu, Saki
    Le, Jason
    Place, Keith
    Hoffelt, Dixon
    Su, Jennifer
    Chen, Ming
    Babineau, Brooke
    McLaughlin, John
    Soe, Myat
    Lin, Winnie
    Bole, Dhruv
    Valentine, Kristen
    Hallam, Liz
    Liu, Serena
    Dhanota, Puja
    Tan, Steven A.
    Zhao, Ben
    Hosur, Raghu
    Poda, Suresh
    Belle, Archana
    Tagliatela, Stephanie
    MOLECULAR THERAPY, 2024, 32 (04) : 270 - 271
  • [28] Toxicity, immunogenicity and biodistribution of AAV2.7m8-ChrimsonR-tdTomato (GS030-DP) gene therapy product after bilateral intravitreal administration in non-human primates
    Bouquet, C.
    Douar, A.
    Pruneau, D.
    Cancian, C.
    Thomasson, N.
    HUMAN GENE THERAPY, 2017, 28 (12) : A75 - A75
  • [29] Lack of Toxicity in Non-Human Primates Receiving Clinically Relevant Doses of an AAV9.U7snRNA Vector Designed to Induce DMD Exon 2 Skipping
    Flanigan, Kevin M.
    Gushchina, Liubov
    Rohan, Natalie
    Frair, Emma
    Bradley, Adrienne
    Suhaiba, Aisha
    Grounds, Kelly
    Huang, Nianyuan
    Simmons, Tabatha
    Waldrop, Megan
    Wein, Nicolas
    MOLECULAR THERAPY, 2020, 28 (04) : 93 - 93
  • [30] Safety and efficacy of pre-treatment with imlifidase prior to AAV-based gene therapy in non-human primates with pre-existing anti-AAVrh74 antibodies
    Potter, R.
    Khan, S.
    Snedeker, J.
    Adegboye, K.
    Haile, A.
    Sayanjali, B.
    Pukos, N.
    Cochran, K.
    Ahner, J.
    Su, T.
    Uzcategui, N.
    Stenberg, Y.
    Freiburghaus, C.
    Winstedt, L.
    Rodino-Klapac, L.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S101 - S101
1234